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Edited by Beat ImhofAbstract In demyelinating diseases, the mechanisms of how
oligodendrocyte (OLG) progenitor cells are aﬀected in the
demyelinated area remain to be elucidated. To investigate one
aspect of the mechanisms, we focused on the role of tenascin C in
regulating the migratory mobility of the progenitor cells via b-
catenin. By cDNA subtraction screening, we found tenascin C
expression to be increased in OLG progenitors (rat primary
O2A cells). Tenascin C inhibited the migration of OLG
progenitors and CG-4 cells, and b-catenin accumulated at focal
adhesions in these cells. These changes were associated with the
inactivation of canonical wnt signaling. Overexpression of the
wnt-signaling antagonist Dapper prevented the migration of CG-
4 cells. This suggests that inactivation of the wnt signal is
responsible for impaired migration of OLG caused by tenascin
C. Our results suggest that tenascin C is involved in the impaired
mobility of OLG progenitor cells through increased amounts of
adhesion complex as well as the prevention of wnt signaling.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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b-Catenin1. Introduction
Autoimmune-mediated demyelination is a major aspect of
the pathogenesis of demyelinating diseases, including multiple
sclerosis (MS). A well-known animal model of human MS is
experimental autoimmune encephalomyelitis (EAE), which is
induced in rodents by the injection of myelin components [1].
In the complicated pathogenesis of EAE or MS, oligoden-
drocytes (OLGs) are believed to be an initial target for the
immune cells. We previously demonstrated that the OLG-
speciﬁc expression of p35, a baculovirus-derived anti-apoptotic* Corresponding author. Fax: +81-3-5841-4867.
E-mail address: miura@mol.f.u-tokyo.ac.jp (M. Miura).
q Grant information: This work was supported in part by grants from
the RIKEN Bioarchitect Research Project and the Japanese Ministry
of Education, Science, Sports, Culture, and Technology to M.M.
Abbreviations: EAE, experimental autoimmune encephalomyelitis;
OLG, oligodendrocyte
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.05.022factor, remarkably inhibits the progression of EAE [2,3]. These
ﬁndings suggest that OLG plays some role in the chronic phase
of pathophysiology of EAE as well as the injury of neuronal
axons does.
During development, OLG progenitor cells initially prolif-
erate speciﬁcally in the ventral neuroepithelial portion of the
neural tube, and from there they migrate and diﬀerentiate into
mature cells that produce myelination-related proteins [4,5].
Therefore, the process of OLG progenitor cells migration
might be crucial, not only for development but also for path-
ophysiological situations. Tenascins are produced by OLG
progenitor cells and also by astrocytes, speciﬁcally as extra-
cellular matrix proteins with roles in adhesion [6], diﬀerentia-
tion [7], and migration [8,9]. However, it remains to be
investigated whether and how tenascin C is involved in path-
ological conditions from the view point of OLG progenitor
migration.
In this study, cDNA subtraction screening showed increased
gene expression of tenascin C in OLG progenitors compared
with mature OLGs.We then investigated how tenascin C aﬀects
the migration of OLGs, and found that it stimulated the ac-
cumulation of b-catenin in the cytoplasmic membrane, but not
in the nucleus, of OLG progenitor cells, in the cultured cell line
CG-4 and in the spinal cords of mice with EAE lesions. Ten-
ascin C inhibited the migration of OLG progenitors in vitro,
suggesting that an accumulation of tenascin C might play a
crucial role in preventing migration of OLG progenitor cells.2. Materials and methods
2.1. Rat primary OLG culture
As previously reported [10], the brains of rat embryos at ED16 were
digested in 0.03% tyrosine–0.03 mM EDTA at 37 C for 5 min, and
inoculated into an 80 cm2 ﬂask containing DME medium with 20%
FBS. After OLG progenitor cells (O2A cells) were detected in the in-
tercellular space between astrocytes, they were separated by manually
shaking the ﬂask. The detached O2A cells were collected and cultured
in DMEM containing 2% FBS and Bottestein and Sato’s supplement
on 100 lg/ml poly-L-lysine-coated dishes [11]. O2A cells, when inoc-
ulated in an aggregated form, started to migrate from the aggregate
leading to a remarkable distribution throughout the dish. The purity of
the primary cultured OLGs was more than 92%, as estimated by im-
munohistochemistry using mouse monoclonal antibodies to CNPase
(1:500; Sigma, Chemical Co., Saint Louis, MO, USA) and A2B5
(1:200; Chemicon International, Temecula, CA, USA).blished by Elsevier B.V. All rights reserved.
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expressed in O2A cells than mature diﬀerentiated oligodendrocytes
The cDNA subtraction assay was performed using the CLONTEC
SMARTTM PCR cDNA Synthesis Kit and PCR-SelectTMcDNA
Subtraction Kit (Clontech Laboratories, Inc., Palo Alto, CA, USA)
[12]. One lg of the total RNA from O2A cells or mature diﬀerentiated
OLGs was reverse-transcribed using an oligo dT primer (cDNA syn-
thesis primer) possessing a speciﬁc DNA element that is suitable for
further PCR ampliﬁcation. The ampliﬁed PCR products were divided
into three groups. Two samples of O2A cDNA (testers) were ligated
with diﬀerent adapters such that each contains a speciﬁc PCR primer
annealing site. A sample of reference (or driver) cDNA was then hy-
bridized with the testers to subtract the many genes expressed at a
similar level between the tester and driver to obtain cDNAs rich in the
tester. PCR using primers possessing the speciﬁc DNA elements that
were found in the adapters ligated to the testers speciﬁcally ampliﬁed
these cDNAs. These PCR products were subcloned and sequenced.
The subtraction was then evaluated again by RT-PCR using primers
targeting the sequenced genes.
2.3. The CG-4 cell line of rat OLG progenitors
As previously reported, CG-4 cells were cultured on poly-L-ornithine
coated dishes in growth medium containing 70% DMEM, 30% con-
ditioned medium from B104 cells, 2% FBS, N1 supplement including
insulin, transferrin, selenite, and progesterone, and biotin [13]. For
diﬀerentiation, CG-4 cells were cultured in DMEM containing N1
supplement but neither FBS nor B104-conditioned medium. After in-
ducing the diﬀerentiation of CG-4 cells, each diﬀerentiated CG-4 eﬃ-
ciently loses the cell–cell contact, and E-cadherin in the adherent
junction between each cell was hardly detected.
2.4. Transfection of CG-4 cells and luciferase assay
To introduce genes into CG-4 cells, we used a cationic reagent, Ef-
fecteneTM (Qiagen, Valencia, CA, USA), according to the manufac-
turer’s protocol. The plasmids transfected in this study contained a wnt
signal antagonist Xenopus Dapper (kindly given by Dr. R.T. Moon,
University of Washington, Seattle, USA) [14], a luciferase reporter
gene for wnt signaling, i.e., TOPFLASH (Upstate Biotechnology,
Lake Placid, NY, USA), and a GFP gene. The cells which were cul-
tured on tenascin C-coated or non-coated dishes were harvested 48 h
after transfection for Western blot analysis or luciferase activity assay.
One hundred lL of the cell lysates was combined with 20 lL of lu-
ciferase assay buﬀer (Promega, Madison, WI, USA). Luciferase ac-
tivity was measured by luminometer with correction of transfection
eﬃciency among the wells.
2.5. Immunocytochemical study using the CG-4 cell line
CG-4 cells were ﬁxed and treated with 0.1% Triton X. After
blocking, the cells were incubated with a polyclonal antibody against
phosphorylated FAK (1:100; Upstate Biotechnology, Lake Placid,
NY, USA), a rabbit anti-GFP antibody (1:500; MBL, Nagoya, Japan)
or a monoclonal antibody against b-catenin (1:300; BD PharMingen,
San Diego, CA, USA). Then, they were followed by reaction with a
FITC-conjugated anti-rabbit IgG antibody or a Cy 3-conjugated anti-
rabbit IgG antibody (Jackson ImmunoResearch Laboratories Inc.,
West Grove, PA, USA).
2.6. Migration assay for primary cultured oligodendrocytes or CG-4
cells
After co-transfection of CG-4 cells with the genes for Dapper and
GFP by EﬀecteneTM, they were collected and the aggregates were
prepared by gentle suspension. They were transferred to the center of
culture dishes coated by BSA (100 lg/ml) or tenascin C (100 lg/ml),
on which the scale bar was present so that the distance of migration
of CG-4 from the center could be easily calculated. Within 24 h since
the transfer, the migratory distance of at least 10 GFP-positive cells
from the center of the aggregate was evaluated and compared with
each other. At least four aggregates from each were used for the
quantiﬁcation.Fig. 1. Gene expression of tenascin C in rat O2A cells. Expression of
tenascin C mRNA in rat O2A was more increased than that in mature
OLG.2.7. Western blot analysis
The samples from rat primary OLG progenitor cells or CG-4 cells
were fractionated by SDS–PAGE and transferred onto membranes
(Millipore Corp., Bedford, MA, USA). The membranes were incu-
bated with a monoclonal b-catenin antibody (1:500), or a monoclonalb-tubulin antibody (1:2000). After the reaction with HRP-conjugated
secondary antibodies, the signal was detected using an enhanced
chemiluminescence system (ECL Plus, Amersham, Buckinghamshire,
UK).3. Results
3.1. Identiﬁcation of the tenascin C gene by its enhanced
expression in OLG progenitor cells
To identify genes that are enriched in OLG progenitors, we
performed subtractive cDNA screening using rat OLG pro-
genitor cells, i.e., O2A. The cDNAs of rat O2A cells were
subtracted by those of mature OLGs. Tenascin C was found to
be among the genes that were more highly expressed in rat
O2A. The level of gene expression of tenascin C was more
elevated in rat O2A than that in mature OLG, evaluated by
RT-PCR (Fig. 1).
3.2. Inhibitory eﬀect of tenascin C on the migration of rat
primary oligodendrocytes and rat OLG progenitor cell line
CG-4
Considering the molecular mechanisms of how tenascin C
aﬀects the function of OLG progenitor cells, we focussed on
migration of the cells and evaluated if there was a direct eﬀect
of tenascin C on the migration of OLG progenitors (rat O2A)
by using tenascin C-coated dishes. O2A showed an initial ad-
hesion in an aggregated form, followed by remarkable mi-
gration away from aggregates after inoculation. The presence
of 100 lg/ml of tenascin C impaired the migration of O2A cells
from aggregates in this system (Fig. 2A), compared to BSA;
however, adhesion to a tenascin C-coated dish was conserved.
The O2A cells cultured on BSA, which was surrounded by
tenascin C, could not move across a margin of tenascin C
(dotted line). On the other hand, O2A cells on the non-tenascin
C-coated part of the dish migrated normally from the aggre-
gates.
To further evaluate the inhibitory eﬀect of tenascin C on
migration, the cell migration assay was also performed using
the rat OLG cell line, CG-4. Tenascin C had the same eﬀect on
CG-4 cell migration as on primary cultured O2A cells
(Fig. 2B). Compared with the control, the migration of CG-4
cells from aggregates was inhibited by tenascin C. However,
CG-4 cells formed aggregates on a tenascin C-coated dish and
further dispersion of CG-4 was inhibited by 100 lg/ml tenascin
C, indicating impaired migration.
3.3. Mechanism responsible for tenascin C-mediated inhibition
of cell migration
To further investigate the molecular mechanisms underlying
the inhibition of OLG migration, we tested whether the wnt
signal is aﬀected by tenascin C. Western blot analysis dem-
Fig. 2. Eﬀect of tenascin C on cell migration of primary cultured rat
OLGs. Primary OLGs did not migrate well on tenascin C (100 lg/ml)-
coated dishes; they tended to form aggregates in comparison with
OLGs plated on dishes coated with 100 lg/ml of BSA (non-tenascin
C)-coated dish (A). The dotted line shows the margin of tenascin C.
Left of the dotted line (tenascin C-coated area), OLGs did not migrate
from aggregates (arrowhead). In contrast, OLGs on the right side
(non-tenascin C but BSA coated area) did not migrate across the
dotted line. Likewise, CG-4 cells did not migrate eﬃciently on tenascin
C (100 lg/ml)-coated dishes and formed aggregates (B). Bar, 20 lm.
Fig. 3. Tenascin C-induced translocation of b-catenin to focal adhe-
sions. b-Catenin (upper bands) expression was greatly increased by
tenascin C as compared with b-tubulin (lower bands) (A). By tenascin
C, more b-catenin was localized to focal adhesions demonstrated by
immunostaining of phosphorylated FAK (pFAK). Bar, 10 lm (B).
Tenascin C (100 lg/ml) increased the amount of membrane-localized
b-catenin with a decrease in the accumulation of nuclear b-catenin (C).
CM: cytoplasmic membrane fraction; N: nuclear fraction. Tenascin C
(100 lg/ml), coated on culture dishes, attenuated luciferase activity
that was transactivated by the nuclear translocation of b-catenin, as
evaluated by TOPFLASH (mean S.E.) (P < 0:01 vs control) (D). An
antagonist of wnt signaling, Dapper, aﬀected the migration of CG-4
cells. CG-4 cells transfected with GFP alone showed eﬃcient migration
compared with cells transfected with GFP and Dapper 30 h after in-
oculation (arrowhead), as also shown by quantitative analysis of the
fold increase in migration distance (meanS.E.) (P < 0:01 vs control)
(E). Dapper also modulated the translocation of b-catenin more to the
focal adhesions, compared with the b-catenin in cells transfected with
GFP alone. Bar, 20 lm (F).
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expression was increased by tenascin C (Fig. 3A). To deter-
mine whether the increased b-catenin was responsible for the
activation of the wnt signal and whether the localization of b-
catenin was altered, we performed immunocytochemistry. In-
terestingly, as shown in Fig. 3B, the b-catenin in CG-4 cells
that were cultured on a tenascin C-coated dish was markedly
localized to focal adhesions which were identiﬁed by immu-
nostaining of phosphorylated FAK, compared with CG-4 cells
cultured on a non-tenascin C-coated dish. Furthermore, the b-
catenin in the cytoplasmic membrane fraction of CG-4 lysates
was greatly increased by tenascin C, whereas in contrast, its
nuclear localization was attenuated by tenascin C (Fig. 3C).
These results suggest that tenascin C facilitates the accumu-
lation of b-catenin at the focal adhesions causing inactivation
of the wnt signal.
These ﬁndings prompted us to speculate that the accumu-
lation of b-catenin at the focal adhesions was responsible for
the inactivation of the wnt signal. To test this possibility, we
performed a luciferase activity assay using TOPFLASH, which
is transactivated by b-catenin located in the nucleus (Fig. 3D).
The luciferase activity was decreased by tenascin C-coating,
consistent with our ﬁnding that more b-catenin was located at
the focal adhesions. This suggested that tenascin C decreasedthe wnt signal in CG-4 cells. Next, to study the involvement of
the tenascin C-induced inhibition of wnt signaling in decreas-
ing the CG-4 cell migration, we expressed a wnt signaling
antagonist, Dapper, which inhibits the b-catenin-mediated
transcriptional activation of wnt in CG-4 cells (Fig. 3E). The
cells transfected with GFP alone migrated eﬃciently away
from the aggregates within 30 h after inoculation. In contrast,
CG-4 cells co-transfected with GFP and Dapper did not mi-
grate markedly from the aggregate. Furthermore, immunocy-
tochemistry demonstrated that Dapper caused them to make
more contact with the dish, compared with control CG-4 cells,
which made few contacts at focal adhesions (Fig. 3F). In
Fig. 3 (continued)
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clusively in the focal adhesions, in comparison with control
CG-4 cells with less b-catenin localized to the focal adhesions.
These results suggest that tenascin C inhibits CG-4 cell mi-
gration by causing b-catenin to accumulate at the focal adhe-
sions, rather than the nucleus, resulting in the inhibition of wnt
signaling.4. Discussion
In the present study, we found that one of the key molecules
involved in the poor mobility of OLG progenitor cells is ten-
ascin C. This molecule inhibits the migration of OLG pro-
genitor cells by causing b-catenin to accumulate at the focal
adhesions, thus inhibiting wnt signaling. Thus, our study elu-
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of wnt signaling.
To elucidate the eﬀect of tenascin C on OLG progenitor
cells, we performed migration assays using CG-4 and O2A
cells. In both these cell types, tenascin C interfered with cell
migration, suggesting that it can inhibit OLG progenitor mi-
gration. This inhibitory eﬀect of tenascin C on the migration of
OLG progenitor cells was also veriﬁed by tenascin C-knockout
mice; our in vitro data are consistent with the previous in vivo
data evaluating the migratory activity of OLG precursors in
tenascin C-knockout mice [15]. These tenascin C-deﬁcient mice
conclusively demonstrated that tenascin C has an inhibitory
eﬀect on the migration of OLG progenitor cells.
As demonstrated in this study, this inhibition of the migra-
tion by tenascin C was accompanied by a translocation of b-
catenin. To further investigate the molecular mechanisms by
which tenascin C transduces an inhibitory eﬀect on migration,
we focused on the wnt signal in OLGs [16]. It is well accepted
that during development, the wnt signal is involved in cell
mobility; however, the role of wnt signaling in pathological
situations remains to be studied [17–19]. In the present study,
tenascin C is known to enhance FAK phosphorylation, which
is accompanied by an elevation of b-catenin expression.
b-Catenin is known to co-localize with cadherin in cell-cell
adhesion. A very restricted localization of b-catenin to the
cytoplasmic membrane with cadherins, and not to the nucleus,
is known to make cells less mobile [20–24]. On the other hand,
a more nuclear than cytoplasmic membrane localization of b-
catenin, a condition associated with more disrupted focal ad-
hesions, tends to make cells migrate [25–27]. Our preliminary
study demonstrated that diﬀerentiated CG-4 cells lose their
contact between each cell and E-cadherin immunoreactivity is
not clearly detected. The present study demonstrated that
tenascin C recruits the b-catenin to the focal adhesion resulting
in the impairment of translocation of b-catenin to the nucleus,
because the transcriptional activity of b-catenin was shown to
be decreased by tenascin C, which was consistent with the
translocation of b-catenin to focal adhesions. This ﬁnding
suggests that blockage of the wnt signal by tenascin C is re-
sponsible for the poor migration. Furthermore, in some tumor
cell lines including melanocytes, elevated b-catenin signaling in
the nucleus causes extensive migration and is responsible for
increased metastasis [27] To investigate whether the wnt signal
is directly involved in OLG progenitor migration, we used
Dapper, an antagonist to wnt signaling [14]. Dapper binds to
wnt signaling molecules including Dishevelled, Axillin, and
GSK-b leading to the antagonization of b-catenin-mediated
nuclear transcriptional activity [14]. In our study, Dapper
clearly enhanced the translocation of b-catenin to the focal
adhesions and inhibited cell migration, suggesting that tenas-
cin C inhibits cell migration by blocking wnt signaling.
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